Elutia Inc (ELUT) Stock Price & Analysis
Elutia Inc (ELUT) — MoonshotScore 26/100 (Weak band), calculated Nov 18, 2026. Price $0.81 (-2.41%), as of the Nov 19, 2026 trading session; market cap $36.0M.
Educational signal · not a buy or sell recommendation · How to read this
Elutia Inc · ELUT · NASDAQ
Elutia Inc. is a commercial-stage biotechnology company specializing in drug-eluting biologics for various medical applications, including neurostimulation and wound care.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Elutia (ELUT)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Weak growth and a full valuation, though the balance sheet is only middling. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Okay; Valuation: Full; Growth Durability: Fading; Momentum: Rising.
- quarterly revenue $1M (Q3 FY2026, quarter ended Sep 30, 2026)
- EPS beat 2 of the last 8 reports
- Altman Z -6.26 · Piotroski F 5
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 25 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak | |
| 26 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.81 | |
| Change on the day | -2.41% | |
| 52-week range | $0.50 – $1.39 | |
| Market capitalisation | $36.0M | — |
| Price / earnings (trailing) | 0.67 | |
| Shares traded on the day | 20.7K |
Price & events
Other perspectives
Council score for Elutia (ELUT): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
3 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 28, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Oct 8, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Oct 8, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Elutia (ELUT), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Elutia Inc (ELUT) is listed on NASDAQ. It employs 26 people and is led by C. Randal Mills. In Q3 FY2026 it reported revenue of $1M and net income of -$1M. The market values it at $36.0M.
What do the latest results show for Elutia (ELUT)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $1M. Against analyst estimates the company has EPS beat 2 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $1M | -$1M | -$0.03 (diluted) |
| Q2 FY2026 | $2M | -$8M | -$0.18 (diluted) |
| Q1 FY2026 | $3M | -$7M | -$0.17 (diluted) |
| Q4 FY2025 | $3M | $71M | $1.48 (diluted) |
What are the financial strengths and risks for Elutia (ELUT)?
Short answer · as of
The distress and quality screens read Altman Z -6.26 · Piotroski F 5. Trailing ratios: ROE 267.7% · current ratio 2.63 · earnings yield 149.7%.
Data-derived red flags
- Listing risk — at $0.81 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
- Financial-distress signal — its Altman Z-Score of -6.26 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
How does Elutia compare with its peers?
Short answer
Elutia's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $420.95 Nov 18, 2026 | $146B | 94 5-pillar Nov 18, 2026 | |
| $13.33 Nov 18, 2026 | $471M | 91 5-pillar Nov 18, 2026 | |
| $9.07 Nov 19, 2026 | $540M | 91 5-pillar Nov 18, 2026 | |
| $3.06 Nov 19, 2026 | $258M | 90 5-pillar Nov 18, 2026 | |
| $42.53 Nov 18, 2026 | $801M | 88 5-pillar Nov 18, 2026 | |
| $15.26 Nov 18, 2026 | $85.5M | 82 5-pillar Nov 18, 2026 | |
| $11.25 Nov 18, 2026 | $102M | 82 5-pillar Nov 18, 2026 | |
| $100.72 Nov 18, 2026 | $129B | 81 5-pillar Nov 18, 2026 | |
| $3.89 Nov 18, 2026 | $169M | 72 5-pillar Nov 18, 2026 | |
| $1.88 Nov 19, 2026 | $178M | 69 5-pillar Nov 18, 2026 | |
| $9.28 Nov 19, 2026 | $545M | 68 5-pillar Nov 18, 2026 | |
| $8.14 Nov 19, 2026 | $796M | 63 5-pillar Nov 18, 2026 | |
| Elutia (ELUT) — this page | $0.81 | $36.0M | 26 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ELUT in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ELUT in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Elutia (ELUT)?
Investor Questions: ELUT Stock
These answers are editorial: 1 of these 9 answers is drawn from the ELUT research dossier (written May 10, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for ELUT?
ELUT carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is ELUT a good stock to buy?
Stock Expert AI does not rate ELUT buy, sell or hold. Elutia Inc carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the ELUT stock price today?
The last price recorded for Elutia Inc (ELUT), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for ELUT?
Elutia Inc. faces several risks, including regulatory challenges that may impact the approval timeline for its products. Additionally, the company operates in a highly competitive environment, where larger firms may overshadow its market presence. Market adoption of new products also poses a risk, as healthcare providers may be hesitant to switch from established solutions.
What are the key factors to evaluate for ELUT?
Elutia Inc (ELUT) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. The regulatory landscape in the U.S. is evolving, with a growing emphasis on expedited pathways for breakthrough technologies, which Elutia can leverage to its advantage. Not financial advice.
How frequently does ELUT data refresh on this page?
ELUT's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven ELUT's recent stock price performance?
Elutia Inc (ELUT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High profit margin indicating strong operational efficiency. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ELUT overvalued or undervalued right now?
The trailing P/E of Elutia Inc (ELUT) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of ELUT?
Fractional-share availability for Elutia Inc (ELUT) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 16 figures on this page — 8 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com